These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 19621344)
1. Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis. Filion KB; Joseph L; Boivin JF; Suissa S; Brophy JM Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):973-6. PubMed ID: 19621344 [TBL] [Abstract][Full Text] [Related]
2. Changes in the management of type 2 diabetic patients in family medicine practices in the Bursa region. Göktaş O; Öz Gül Ö; Ertürk E Prim Care Diabetes; 2017 Apr; 11(2):178-183. PubMed ID: 27852516 [TBL] [Abstract][Full Text] [Related]
3. Changes in time to insulin initiation in type 2 diabetes patients: a retrospective database analysis in Germany and UK (2005-2010). Kostev K; Rathmann W Prim Care Diabetes; 2013 Oct; 7(3):229-33. PubMed ID: 23608219 [TBL] [Abstract][Full Text] [Related]
4. Initial treatment of diabetes in Italy. A nationwide population-based study from of the ARNO Diabetes Observatory. Bonora E; Cataudella S; Marchesini G; Miccoli R; Vaccaro O; Fadini GP; Martini N; Rossi E; Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2661-2668. PubMed ID: 34218990 [TBL] [Abstract][Full Text] [Related]
5. Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales. Datta-Nemdharry P; Thomson A; Beynon J; Donegan K Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):127-135. PubMed ID: 27642000 [TBL] [Abstract][Full Text] [Related]
6. Trends in the prescription of antidiabetic medications in France: evidence from primary care physicians. Boyc KS; Yurgin N; Lage MJ Adv Ther; 2007; 24(4):803-13. PubMed ID: 17901029 [TBL] [Abstract][Full Text] [Related]
7. Secular trends in antihyperglycaemic medication prescriptions in older adults with diabetes and chronic kidney disease: 2004-2013. Clemens KK; Liu K; Shariff S; Schernthaner G; Tangri N; Garg AX Diabetes Obes Metab; 2016 Jun; 18(6):607-14. PubMed ID: 26939711 [TBL] [Abstract][Full Text] [Related]
8. Approaches to treatment 1: How is type 2 diabetes actually treated? Bloomgarden ZT J Diabetes; 2015 Nov; 7(6):747-8. PubMed ID: 26211568 [No Abstract] [Full Text] [Related]
9. A changed pattern of insulin use following the introduction of basal analog insulin treatment in primary care. Heymann AD; Kritz V; Hemo B; Kertes J; Becker M Prim Care Diabetes; 2013 Apr; 7(1):57-61. PubMed ID: 23352415 [TBL] [Abstract][Full Text] [Related]
10. Treatment Patterns in Patients With Newly Diagnosed Type 2 Diabetes in China: A Retrospective, Longitudinal Database Study. Wang C; Gao Y; Zhu L; Huang M; Wu Y; Xuan J Clin Ther; 2019 Aug; 41(8):1440-1452. PubMed ID: 31155146 [TBL] [Abstract][Full Text] [Related]
11. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study. Yurgin N; Secnik K; Lage MJ Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823 [TBL] [Abstract][Full Text] [Related]
12. A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patients. Davidson J; Koro C; Arondekar B; Lee BH; Fedder D Clin Ther; 2008 Feb; 30(2):287-93. PubMed ID: 18343267 [TBL] [Abstract][Full Text] [Related]
13. A population-based analysis of antidiabetic medications in four Canadian provinces: Secular trends and prescribing patterns. Secrest MH; Azoulay L; Dahl M; Clemens KK; Durand M; Hu N; Targownik L; Turin TC; Dormuth CR; Filion KB Pharmacoepidemiol Drug Saf; 2020 Jan; 29 Suppl 1():86-92. PubMed ID: 31464069 [TBL] [Abstract][Full Text] [Related]
14. How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study. Penfornis A; Blicklé JF; Fiquet B; Quéré S; Dejager S Vasc Health Risk Manag; 2014; 10():341-52. PubMed ID: 24966684 [TBL] [Abstract][Full Text] [Related]
15. Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria. Yusuff KB; Obe O; Joseph BY Pharm World Sci; 2008 Dec; 30(6):876-83. PubMed ID: 18784982 [TBL] [Abstract][Full Text] [Related]
16. Results from the UK cohort of SOLVE: providing insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice. Khunti K; Vora J; Davies M Prim Care Diabetes; 2014 Apr; 8(1):57-63. PubMed ID: 24378771 [TBL] [Abstract][Full Text] [Related]
17. Unlicensed use of metformin in children and adolescents in the UK. Hsia Y; Dawoud D; Sutcliffe AG; Viner RM; Kinra S; Wong IC Br J Clin Pharmacol; 2012 Jan; 73(1):135-9. PubMed ID: 21762204 [TBL] [Abstract][Full Text] [Related]
18. Dapagliflozin therapy for type 2 diabetes in primary care: Changes in HbA1c, weight and blood pressure over 2 years follow-up. Wilding J; Bailey C; Rigney U; Blak B; Kok M; Emmas C Prim Care Diabetes; 2017 Oct; 11(5):437-444. PubMed ID: 28583425 [TBL] [Abstract][Full Text] [Related]
19. Guidelines adherence in the treatment of patients with newly diagnosed type 2 diabetes: a historical cohort comparing the use of metformin in Quebec pre and post-Canadian Diabetes Association guidelines. Wang TY; Eguale T; Tamblyn R BMC Health Serv Res; 2013 Oct; 13():442. PubMed ID: 24160916 [TBL] [Abstract][Full Text] [Related]
20. Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995-2015. Renoux C; Shin JY; Dell'Aniello S; Fergusson E; Suissa S Br J Clin Pharmacol; 2016 Sep; 82(3):858-68. PubMed ID: 27145886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]